Cited by 1,115Pluripotent Stem Cells ResearchDevelopmental Biology and Gene RegulationCancer-related Molecular Pathways

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Open access

Kawamura, Teruhisa, Suzuki, Jotaro, Wang, Yunyuan V., Menendez, Sergio, Morera, Laura Batlle, Raya, Angel, Wahl, Geoffrey M., Belmonte, Juan Carlos Izpisúa·2009·Nature

DOI 10.1038/nature08311PMC PMC2735889

Open this paper in CoChat — free account

Abstract

Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes, but the low frequency and tendency to induce malignant transformation compromise the clinical utility of this powerful approach. We address both issues by investigating the mechanisms limiting reprogramming efficiency in somatic cells. Here we show that reprogramming factors can activate the p53 (also known as Trp53 in mice, TP53 in humans) pathway. Reducing signalling to p53 by expressing a mutated version of one of its negative regulators, by deleting or knocking down p53 or its target gene, p21 (also known as Cdkn1a), or by antagonizing reprogramming-induced apoptosis in mouse fibroblasts increases reprogramming efficiency. Notably, decreasing p53 protein levels enabled fibroblasts to give rise to iPS cells capable of generating germline-transmitting chimaeric mice using only Oct4 (also known as Pou5f1) and Sox2. Furthermore, silencing of p53 significantly increased the reprogramming efficiency of human somatic cells. These results provide insights into reprogramming mechanisms and suggest new routes to more efficient reprogramming while minimizing the use of oncogenes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature08311

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626

Show all 40 references

Sorted by citations

Items 501–600 of 1,000

FAK and Nanog Cross Talk with p53 in Cancer Stem Cells
Golubovskaya, V. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313040006 · Cited by 29
Methods for iPS cell generation for basic research and clinical applications
Mochiduki, Y., & Okita, K. (2012) · Biotechnology Journal · doi:10.1002/biot.201100356 · Cited by 31
Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming
Armstrong, L. C., Westlake, G. M., Snow, J. P., Cawthon, B., Armour, E. A., Bowman, A. B., & Ess, K. C. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx345 · Cited by 31
Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression
Zhang, L., Peng, L., Hsu, T., Aguilar, H. R., Frantz, D. E., Schneider, J. W., Bachoo, R. M., & Hsieh, J. (2011) · Differentiation · doi:10.1016/j.diff.2011.02.005 · Cited by 31
Mitochondrial metabolism transition cooperates with nuclear reprogramming during induced pluripotent stem cell generation
Liu, W., Long, Q., Chen, K., Li, S., Xiang, G., Chen, S., Li, Y., Li, Y., Yang, L., Dong, D., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.148 · Cited by 29
High-Risk Human Papillomavirus E6 Protein Promotes Reprogramming of Fanconi Anemia Patient Cells through Repression of p53 but Does Not Allow for Sustained Growth of Induced Pluripotent Stem Cells
Chlon, T. M., Hoskins, E. E., Mayhew, C. N., Wikenheiser‐Brokamp, K. A., Davies, S. M., Mehta, P. A., Myers, K. C., Wells, J. M., & Wells, S. I. (2014) · Journal of Virology · doi:10.1128/jvi.01533-14 · Cited by 30
Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration
Hunkler, H. J., Groß, S., Thum, T., & Bär, C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab335 · Cited by 31
MicroRNA Roles in Cell Reprogramming Mechanisms
Pascale, E., Caiazza, C., Paladino, M., Parisi, S., Passaro, F., & Caiazzo, M. (2022) · Cells · doi:10.3390/cells11060940 · Cited by 30
RUNX3 in Stem Cell and Cancer Biology
Chuang, L. S. H., Matsuo, J., Douchi, D., Mawan, N. A., & Ito, Y. (2023) · Cells · doi:10.3390/cells12030408 · Cited by 30
Cell Cycle Adaptations and Maintenance of Genomic Integrity in Embryonic Stem Cells and Induced Pluripotent Stem Cells
Momčilović, O., Navara, C. S., & Schatten, G. P. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-19065-0_18 · Cited by 30
NKX2.2 Suppresses Self-Renewal of Glioma-Initiating Cells
Muraguchi, T., Tanaka, S., Yamada, D., Tamase, A., Nakada, M., Nakamura, H., Hoshii, T., Ooshio, T., Tadokoro, Y., Naka, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2304 · Cited by 30
Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy
Vicente‐Dueñas, C., Hauer, J., Ruiz-Roca, L., Ingenhag, D., Rodríguez-Meira, A., Auer, F., Borkhardt, A., & Sánchez-Garcı́a, I. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.001 · Cited by 31
Lats2 is critical for the pluripotency and proper differentiation of stem cells
Aylon, Y., Sarver, A. L., Tovy, A., Ainbinder, E., & Oren, M. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2013.188 · Cited by 29
FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition
Firat, E., & Niedermann, G. (2016) · Oncotarget · doi:10.18632/oncotarget.10702 · Cited by 30
Gadd45a is a heterochromatin relaxer that enhances iPS cell generation
Chen, K., Long, Q., Wang, T., Zhao, D., Zhou, Y., Qi, J., Wu, Y., Li, S., Chen, C., Zeng, X., et al. (2016) · EMBO Reports · doi:10.15252/embr.201642402 · Cited by 37
p53 and its mutants on the slippery road from stemness to carcinogenesis
Molchadsky, A., & Rotter, V. (2017) · Carcinogenesis · doi:10.1093/carcin/bgw092 · Cited by 30
Cancer Epigenetics: From Disruption of Differentiation Programs to the Emergence of Cancer Stem CellsPreprint
Scaffidi, P., & Misteli, T. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.007 · Cited by 33
Reprogramming cell fate to pluripotency: the decision-making signalling pathways
Sanges, D., & Cosma, M. P. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103190ds · Cited by 29
Genome damage in induced pluripotent stem cells: Assessing the mechanisms and their consequences
Hussein, S. M. I., Elbaz, J., & Nagy, A. (2012) · BioEssays · doi:10.1002/bies.201200114 · Cited by 29
Profiling of MicroRNA in Human and Mouse ES and iPS Cells Reveals Overlapping but Distinct MicroRNA Expression Patterns
Razak, S. R. A., Ueno, K., Takayama, N., Nariai, N., Nagasaki, M., Saito, R., Koso, H., Lai, C., Murakami, M., Tsuji, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073532 · Cited by 29
Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency
Lee, Y. J., Ramakrishna, S., Chauhan, H., Park, W. S., Hong, S., & Kim, K.-S. (2016) · Cell Regeneration · doi:10.1186/s13619-016-0028-0 · Cited by 28
Efficient induction and sustenance of pluripotent stem cells from bovine somatic cells
Pillai, V. V., Koganti, P. P., Kei, T. G., Gurung, S., Butler, W. R., & Selvaraj, V. (2021) · Biology Open · doi:10.1242/bio.058756 · Cited by 22
TP53 promotes lineage commitment of human embryonic stem cells through ciliogenesis and sonic hedgehog signaling
Sivakumar, S., Qi, S., Cheng, N., Sathe, A. A., Kanchwala, M., Kumar, A., Evers, B. M., Xing, C., & Yu, H. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110395 · Cited by 28
Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming
von Joest, M., Chen, C., Douché, T., Chantrel, J., Chiche, A., Gianetto, Q. G., Matondo, M., & Li, H. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111074 · Cited by 31
Genetic instability of modified stem cells - a first step towards malignant transformation?
Steinemann, D., Göhring, G., & Schlegelberger, B. (2013) · Europe PMC (PubMed Central) · Cited by 29
Airway basal cells of healthy smokers express an embryonic stem cell signature relevant to lung cancer
Shaykhiev, R., Wang, R., Zwick, R. K., Hackett, N. R., Leung, R., Moore, M. A. S., Sima, C. S., Chao, I. W., Downey, R. J., Strulovici‐Barel, Y., et al. (2013) · Stem Cells · doi:10.1002/stem.1459 · Cited by 29
Failsafe program escape and EMT: A deleterious partnership
Ansieau, S., Courtois-Cox, S., Morel, A., & Puisieux, A. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.014 · Cited by 31
Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig
Choi, K., Park, J., Son, D.-C., Hwang, J. Y., Lee, D., Ka, H., Park, J., & Lee, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158046 · Cited by 29
Melatonin improves the reprogramming efficiency of murine‐induced pluripotent stem cells using a secondary inducible system
Gao, S., Wang, Z., Di, K., Chang, G., Tao, L., An, L., Wu, F., Xu, J., Liu, Y., Wu, Z., et al. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12047 · Cited by 28
NANOG priming before full reprogramming may generate germ cell tumours
Service de gynécologie obstétrique, H. F. H. C., Grad, I., Hibaoui, Y., Jaconi, M. E., Chicha, L., Bergström-Tengzelius, R., Sailani, M. R., Pelte, M., Dahoun, S. P., Mitsiadis, T. A., et al. (2011) · European Cells and Materials · doi:10.22203/ecm.v022a20 · Cited by 29
Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer
Prieto, J., & Torres, J. (2017) · Stem Cells International · doi:10.1155/2017/8073721 · Cited by 26
Cell cycle dynamics in the reprogramming of cellular identity
Hu, X., Eastman, A. E., & Guo, S. (2019) · FEBS Letters · doi:10.1002/1873-3468.13625 · Cited by 28
A connection in life and death: The BCL-2 family coordinates mitochondrial network dynamics and stem cell fate
Rasmussen, M. L., & Gama, V. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2019.12.005 · Cited by 29
PTEN and TRP53 Independently Suppress Nanog Expression in Spermatogonial Stem Cells
Kuijk, E., van Mil, A., Brinkhof, B., Penning, L. C., Colenbrander, B., & Roelen, B. A. J. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0276 · Cited by 28
The propensity for tumorigenesis in human induced pluripotent stem cells is related with genomic instability
Liang, Y., Zhang, H., Feng, Q., Cai, M.-B., Deng, W., Qin, D., Yun, J., Tsao, G. S., Kang, T., Esteban, M. A., et al. (2012) · 癌症：英文版 · doi:10.5732/cjc.012.10065 · Cited by 32
Synergetic Cooperation of microRNAs with Transcription Factors in iPS Cell Generation
Chen, J., Wang, G., Lu, C., Guo, X., Hong, W., Kang, J., & Wang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040849 · Cited by 28
Acetylation‐dependent regulation of essential iPS ‐inducing factors: a regulatory crossroad for pluripotency and tumorigenesis
Dai, X., Liu, P., Lau, A. W., Liu, Y., & Inuzuka, H. (2014) · Cancer Medicine · doi:10.1002/cam4.298 · Cited by 29
Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming
Ward, C., Volpe, G., Cauchy, P., Ptasinska, A., Almaghrabi, R. O. M., Blakemore, D., Nafria, M., Kestner, D., Frampton, J., Murphy, G. J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.026 · Cited by 26
Efficiencies and Mechanisms of Nuclear ReprogrammingPreprint
Pasque, V., Miyamoto, K., & Gurdon, J. B. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.002 · Cited by 27
An introduction to induced pluripotent stem cells
Hanley, J., Rastegarlari, G., & Nathwani, A. C. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08296.x · Cited by 28
Conversion of Fibroblasts to Neural Cells by p53 Depletion
Zhou, D., Zhang, Z., He, L.-M., Du, J., Zhang, F., Sun, C.-K., Zhou, Y., Wang, X., Lin, G., Song, K.-M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.040 · Cited by 29
New approaches for the generation of induced pluripotent stem cells
Sidhu, K. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.558837 · Cited by 27
Deubiquitylating enzymes as cancer stem cell therapeutics
Haq, S., Suresh, B., & Ramakrishna, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.10.004 · Cited by 27
The POU5F1 gene expression in colorectal cancer: a novel prognostic marker
Miyoshi, N., Fujino, S., Ohue, M., Yasui, M., Takahashi, Y., Sugimura, K., Tomokuni, A., Akita, H., Kobayashi, S., Takahashi, H., et al. (2018) · Surgery Today · doi:10.1007/s00595-018-1644-9 · Cited by 27
Active Fraction from Embryo Fish Extracts Induces Reversion of the Malignant Invasive Phenotype in Breast Cancer through Down-Regulation of TCTP and Modulation of E-cadherin/β-catenin Pathway
Proietti, S., Cucina, A., Pensotti, A., Biava, P. M., Minini, M., Monti, N., Catizone, A., Ricci, G., Leonetti, E., Harrath, A. H., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092151 · Cited by 27
Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity
Menéndez, J. A. (2020) · Biomolecules · doi:10.3390/biom10050780 · Cited by 27
The p53 inhibitor, pifithrin-α, suppresses self-renewal of embryonic stem cells
Abdelalim, E. M., & Tooyama, I. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.041 · Cited by 28
Combined Overexpression of JARID2, PRDM14, ESRRB, and SALL4A Dramatically Improves Efficiency and Kinetics of Reprogramming to Induced Pluripotent Stem Cells
Iseki, H., Nakachi, Y., Hishida, T., Yamashita-Sugahara, Y., Hirasaki, M., Ueda, A., Tanimoto, Y., Iijima, S., Sugiyama, F., Yagami, K., et al. (2015) · Stem Cells · doi:10.1002/stem.2243 · Cited by 27
Genetic background affects induced pluripotent stem cell generation
Schnabel, L. V., Abratte, C. M., Schimenti, J. C., Southard, T. L., & Fortier, L. A. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt121 · Cited by 27
Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells
Okuda, A., Kurokawa, S., Takehashi, M., Maeda, A., Fukuda, K., Kubo, Y., Nogusa, H., Takatani‐Nakase, T., Okuda, S., Ueda, K., et al. (2017) · BMC Neuroscience · doi:10.1186/s12868-016-0333-0 · Cited by 27
Induced pluripotent stem cells (iPSCs)—a new era of reprogramming
Kang, L., Kou, Z., Zhang, Y., & Gao, S. (2010) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(09)60060-6 · Cited by 26
Clinical Grade iPS Cells: Need for Versatile Small Molecules and Optimal Cell Sources
Wu, Y., Pandian, G. N., Ding, Y., Zhang, W., Tanaka, Y., & Sugiyama, H. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.016 · Cited by 27
Downregulation of the Genes Involved in Reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in Gastric Adenocarcinoma
Khalili, M., Vasei, M., Khalili, D., Alimoghaddam, K., Sadeghizadeh, M., & Mowla, S. J. (2015) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-015-9695-2 · Cited by 25
Energy Metabolism and Metabolic Sensors in Stem Cells: The Metabostem Crossroads of Aging and Cancer
Menéndez, J. A., & Joven, J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_10 · Cited by 27
Overexpression of cyclin D1 induces the reprogramming of differentiated epidermal cells into stem cell-like cells
Zhao, A., Yang, L., Ma, K., Sun, M., Li, L., Huang, J., Li, Y., Zhang, C., Li, H., & Fu, X. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1146838 · Cited by 26
KATapulting toward Pluripotency and Cancer
Hirsch, C. L., Wrana, J. L., & Dent, S. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.09.023 · Cited by 27
Suv4-20h Abrogation Enhances Telomere Elongation during Reprogramming and Confers a Higher Tumorigenic Potential to iPS Cells
Marión, R. M., Schotta, G., Ortega, S., & Blasco, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025680 · Cited by 26
Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells
Lin, Y., Murayama, Y., Hashimoto, K., Nakamura, Y., Lin, C.-S., Yokoyama, K. K., & Saito, S. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt447 · Cited by 27
Cell-Cycle Regulation in Embryonic Stem Cells: Centrosomal Decisions on Self-Renewal
Koledova, Z. S., Krämer, A., Kafkova, L. R., & Divoký, V. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0136 · Cited by 27
Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2–p53 Interaction in Mucoepidermoid Carcinoma
Andrews, A., Warner, K. A., Rodriguez-Ramirez, C., Pearson, A. T., Nör, F., Zhang, Z., Kerk, S. A., Kulkarni, A., Helman, J. I., Brenner, J. C., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2730 · Cited by 26
Somatic cell nuclear reprogramming of mouse oocytes endures beyond reproductive decline
Esteves, T. C., Balbach, S. T., Pfeiffer, M. J., Araúzo-Bravo, M. J., Klein, D., Sinn, M., & Boiani, M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00644.x · Cited by 26
DNp73 improves generation efficiency of human induced pluripotent stem cells
Lin, Y., Cheng, Z., Yang, Z., Zheng, J., & Lin, T. (2012) · BMC Cell Biology · doi:10.1186/1471-2121-13-9 · Cited by 28
Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies
Pratumkaew, P., Issaragrisil, S., & Luanpitpong, S. (2021) · Cells · doi:10.3390/cells10113250 · Cited by 25
Behind the scenes: Unravelling the molecular mechanisms of p53 target gene selectivity (Review)
Lohrum (2010) · International Journal of Oncology · doi:10.3892/ijo_00000757 · Cited by 24
Generation of Induced Pluripotent Stem Cells from Somatic Cells
Sohn, Y.-D., Han, J. W., & Yoon, Y. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398459-3.00001-0 · Cited by 25
Survival Signalling in the Preimplantation Embryo
O’Neill, C., Li, Y., & Jin, X. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2480-6_5 · Cited by 25
MicroRNA-mediated regulation of extracellular matrix formation modulates somatic cell reprogramming
Li, Z., Dang, J. W., Chang, K., & Rana, T. M. (2014) · RNA · doi:10.1261/rna.043745.113 · Cited by 24
MYD88 signals induce tumour-initiating cell generation through the NF-κB-HIF-1α activation cascade
Tanimura, A., Nakazato, A., & Tanaka, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-83603-4 · Cited by 22
A highly sensitive fluorescent light-up probe for real-time detection of the endogenous protein target and its antagonism in live cells
Geng, J., Goh, W. L., Zhang, C., Lane, D. P., Liu, B., Ghadessy, F. J., & Tan, Y. N. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00819k · Cited by 24
Tumoral reprogramming: Plasticity takes a walk on the wild side
Campos‐Sánchez, E., & Cobaleda, C. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.07.003 · Cited by 24
Integrated Transcriptome and Binding Sites Analysis Implicates E2F in the Regulation of Self-Renewal in Human Pluripotent Stem Cells
Yeo, H. C., Beh, T. T., Quek, J. J. L., Koh, G., Chan, K. K., & Lee, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027231 · Cited by 27
Cell death, non‐invasively assessed by intrinsic fluorescence intensity of NADH, is a predictive indicator of functional differentiation of embryonic stem cells
Buschke, D. G., Squirrell, J. M., Fong, J. J., Eliceiri, K. W., & Ogle, B. M. (2012) · Biology of the Cell · doi:10.1111/boc.201100091 · Cited by 24
Hsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process
Tsuno, S., Wang, X., Shomori, K., Hasegawa, J., & Miura, N. (2014) · Scientific Reports · doi:10.1038/srep03852 · Cited by 24
Retracted
The Wnt/β-Catenin Signaling Pathway Tips the Balance Between Apoptosis and Reprograming of Cell Fusion Hybrids
Lluı́s, F., Pedone, E., Pepe, S., & Cosma, M. P. (2010) · Stem Cells · doi:10.1002/stem.515 · Cited by 25
The impact of cellular senescence in cancer therapy: is it true or not?
Zhang, Y., & Yang, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.108 · Cited by 24
p53, stem cell biology and childhood blastomas
Oh, L., Hafsi, H., Hainaut, P. L., & Ariffin, H. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000504 · Cited by 23
Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer
Mori, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1346 · Cited by 24
Reprogramming adult hematopoietic cells
Kaneko, S., Otsu, M., & Nakauchi, H. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32833a25ee · Cited by 24
Eliminate, Reprogram, and Rebuild
Tkemaladze, J. (2026) · Longevity Horizon · doi:10.65649/amb5zx11 · Cited by 27
Mechanisms underlying the formation of induced pluripotent stem cells
Gonzãlez, F., & Huangfu, D. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.206 · Cited by 24
ΔNp63 regulates select routes of reprogramming via multiple mechanisms
Alexandrova, E. M., Petrenko, O., Nemajerová, A., Romano, R.-A., Sinha, S., & Moll, U. M. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.122 · Cited by 23
Increase developmental plasticity of human keratinocytes with gene suppression
Li, S. C., Jin, Y.-S., Loudon, W. G., Song, Y., Ma, Z., Weiner, L. P., & Zhong, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100509108 · Cited by 23
Application of induced pluripotent stem cells to hematologic disease
Kim, P. G., & Daley, G. Q. (2009) · Cytotherapy · doi:10.3109/14653240903348319 · Cited by 23
p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming
Martín‐López, M., Maeso‐Alonso, L., Fuertes-Álvarez, S., Balboa, D., Rodríguez-Cortez, V., Weltner, J., Diez-Prieto, I., Davis, A. J., Wu, Y., Otonkoski, T., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.432 · Cited by 23
Key autophagic targets and relevant small‐molecule compounds in cancer therapy
Tong, X. ‐., Chen, Y., Zhang, S. ‐., Xie, T., Tian, M., Guo, M., Kasimu, R., Ouyang, L., & Wang, J. ‐. (2014) · Cell Proliferation · doi:10.1111/cpr.12154 · Cited by 23
Cellular reprogramming in skin cancer
Song, I. Y., & Balmain, A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.03.006 · Cited by 24
Exploiting cellular senescence to treat cancer and circumvent drug resistance
Yan, Q., & Wajapeyee, N. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.3.11166 · Cited by 24
Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts
Kitajima, S., Kohno, S., Kondoh, A., Sasaki, N., Nishimoto, Y., Li, F., Mohammed, M. S. A., Muranaka, H., Nagatani, N., Suzuki, M., et al. (2015) · Stem Cells · doi:10.1002/stem.1971 · Cited by 24
Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming
Vaseghi, H. R., Yin, C., Zhou, Y., Wang, L., Liu, J., & Li, Q. (2016) · genesis · doi:10.1002/dvg.22947 · Cited by 22
Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4
Corbineau, S., Lassalle, B., Givelet, M., Souissi, I., Firlej, V., Roméo, P., Allemand, I., Riou, L., & Fouchet, P. (2016) · Oncotarget · doi:10.18632/oncotarget.14327 · Cited by 23
Baf60b-mediated ATM-p53 activation blocks cell identity conversion by sensing chromatin opening
Ji, S., Zhu, L., Gao, Y., Zhang, X., Yan, Y., Cen, J., Li, R., Zeng, R., Liao, L., Hou, C., et al. (2017) · Cell Research · doi:10.1038/cr.2017.36 · Cited by 23
The essentiality of non-coding RNAs in cell reprogramming
Luginbühl, J., Sivaraman, D. M., & Shin, J. W. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.04.002 · Cited by 23
Modeling myeloid malignancies with patient-derived iPSCs
Papapetrou, E. P. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.11.006 · Cited by 23
Developmental Acquisition of p53 Functions
Jaiswal, S. K., Raj, S., & Depamphilis, M. (2021) · Genes · doi:10.3390/genes12111675 · Cited by 23
Analysis of chromatin accessibility in p53 deficient spermatogonial stem cells for high frequency transformation into pluripotent state
Liu, S., Wei, R., Liu, H., Liu, R., Li, P., Zhang, X., Wei, W., Zhao, X., Li, X., Yang, Y., et al. (2022) · Cell Proliferation · doi:10.1111/cpr.13195 · Cited by 22
Cancer cells as a new source of induced pluripotent stem cells
Shamsian, A., Sahebnasagh, R., Norouzy, A., Hussein, S. H., Ghahremani, M. H., & Azizi, Z. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03145-y · Cited by 22
Glucose Metabolism, Hyperosmotic Stress, and Reprogramming of Somatic Cells
Madonna, R., Görbe, A., Ferdinandy, P., & Caterina, R. D. (2013) · Molecular Biotechnology · doi:10.1007/s12033-013-9668-2 · Cited by 22
Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells byMafB
Vicente‐Dueñas, C., González‐Herrero, I., Cenador, M. B. G., Criado, F. J. G., & Sánchez-Garcı́a, I. (2012) · Cell Cycle · doi:10.4161/cc.22186 · Cited by 22
Generation and genetic modification of induced pluripotent stem cells
Schambach, A., Cantz, T., Baum, C., & Cathomen, T. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.496775 · Cited by 22
Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling
Hsu, Y., Chen, C.-T., & Wei, Y. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.009 · Cited by 22

Authors: Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I.
Affiliations: Salk Institute for Biological Studies (US)
Corresponding author: Wahl, Geoffrey M.
Belmonte, Juan Carlos Izpisúa
ORCID: Kawamura, Teruhisa
Wahl, Geoffrey M.
Belmonte, Juan Carlos Izpisúa
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2009-08
Volume: 460
Issue: 7259
Pages: 1140-1144
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature08311
PMC: PMC2735889
OpenAlex: W2070672434
Cited by: 1,115
References: 40
Citations by year: 2026: 13 · 2025: 12 · 2024: 30 · 2023: 34 · 2022: 31 · 2021: 36 · 2020: 29 · 2019: 41 · 2018: 55 · 2017: 60 · 2016: 65 · 2015: 77 · 2014: 96 · 2013: 111 · 2012: 136
FWCI: 57.10
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (R33HL088293)
National Cancer Institute (R01CA100845, R01CA061449)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: p53, somatic cell reprogramming, induced pluripotent stem cells, Oct4, SOX2, p21, Nutlin-3, reprogramming efficiency, malignant transformation, fibroblasts, oncogenes, apoptosis
MeSH terms: Animals, Cells, Cultured, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Mice, Inbred C57BL, Down-Regulation, Keratinocytes, Tumor Suppressor Protein p53, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks